FIV.DEFIV.DEXETRA
Loading
Cash Flow Under PressureContracting
Percentile Rank93
3Y CAGR+11.4%
5Y CAGR+6.0%
Year-over-Year Change
Operating cash flow minus capital expenditures
3Y CAGR
+11.4%/yr
vs +27.4%/yr prior
5Y CAGR
+6.0%/yr
Recent acceleration
Acceleration
-16.0pp
Decelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.3x
Solid growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $4.34B | -14.2% |
| 2024 | $5.06B | +34.1% |
| 2023 | $3.77B | +20.2% |
| 2022 | $3.14B | +9.2% |
| 2021 | $2.87B | -11.5% |
| 2020 | $3.25B | +56.6% |
| 2019 | $2.07B | +74.0% |
| 2018 | $1.19B | -0.3% |
| 2017 | $1.20B | +4.8% |
| 2016 | $1.14B | - |